卵巣がん治療薬:世界の治験レビュー(2020年上半期)

◆英語タイトル:Ovarian Cancer Global Clinical Trials Review, H1, 2020
◆商品コード:GDATA20MY1111
◆発行会社(リサーチ会社):GlobalData
◆発行日:2020年2月5日
◆ページ数:2121
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥525,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD7,500 ⇒換算¥787,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Ovarian Cancer Global Clinical Trials Review, H1, 2020
Summary

GlobalData’s clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H1, 2020″ provides an overview of Ovarian Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Ovarian Cancer to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Ovarian Cancer to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Ovarian Cancer Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Ovarian Cancer
Nov 27, 2019: Photosoft technology shrinks ovarian cancer by more than half
Nov 26, 2019: Soricimed announces Journal of Cancer publication identifying TRPV6 as a promising target for cancer therapy
Nov 20, 2019: Aravive reports positive data supporting relationship between AVB-500 levels, anti-tumor activity and progression free survival in women with ovarian cancer
Nov 18, 2019: Fujifilm starts a U.S. phase I clinical trial of anti-cancer agent “FF-10850” on Advanced Solid Tumors
Nov 15, 2019: Secondary surgical cytoreduction followed by chemotherapy vs chemotherapy in Recurrent Ovarian Cancer
Nov 14, 2019: Race reveals new strategy for cancer drug Bisantrene
Nov 12, 2019: Oncology Venture advancing towards next milestone in its clinical development of 2X-121.
Nov 11, 2019: ORYX confirms ParvOryx mode of action in tumor explant model
Nov 09, 2019: NextCure Presents Updated Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of Society for Immunotherapy of Cancer (SITC) and Announces Initiation of Phase 2 Portion of the Trial
Nov 07, 2019: MaxCyte to present at BIO-Europe 2019
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Ovarian Cancer Therapeutics, Global, Clinical Trials by Region, 2020*
Ovarian Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
Ovarian Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
Ovarian Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
Ovarian Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
Ovarian Cancer Therapeutics Clinical Trials, North America, Top Countries, 2020*
Ovarian Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
Ovarian Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
Proportion of Ovarian Cancer to Oncology Clinical Trials, G7 Countries (%), 2020*
Ovarian Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
Ovarian Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
Proportion of Ovarian Cancer to Oncology Clinical Trials, E7 Countries (%), 2020*
Ovarian Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
Ovarian Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
Ovarian Cancer Therapeutics, Global, Clinical Trials by Phase, 2020*
Ovarian Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
Ovarian Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2020*
Ovarian Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2020*
Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
Ovarian Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
Ovarian Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
Ovarian Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

【掲載企業】

F. Hoffmann-La Roche Ltd
AstraZeneca Plc
GlaxoSmithKline Plc
Merck & Co Inc
Bristol-Myers Squibb Co
Novartis AG
Pfizer Inc
Eli Lilly and Co
Sanofi
Amgen Inc

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[卵巣がん治療薬:世界の治験レビュー(2020年上半期)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆